Discovery of a ligand that compensates for decreased endogenous agonist potency of melanocortin-4 receptor polymorphisms identified in obese humans.

0Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Haskell-Luevano, C., Xiang, Z., Wilczynski, A. M., Haskell, K. R., Andreasen, A. M., Litherland, S. A., … Sorenson, N. B. (2009). Discovery of a ligand that compensates for decreased endogenous agonist potency of melanocortin-4 receptor polymorphisms identified in obese humans. Advances in Experimental Medicine and Biology, 611, 509–510. https://doi.org/10.1007/978-0-387-73657-0_221

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free